Spots Global Cancer Trial Database for Prospective Randomized Trial of Streamlined Genetic Education and Testing for Ovarian Cancer Patients

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Prospective Randomized Trial of Streamlined Genetic Education and Testing for Ovarian Cancer Patients

Official Title: Prospective, Randomized Non-inferiority Trial of Streamlined Genetic Education and Testing for High-grade Epithelial Ovarian, Fallopian and Peritoneal Cancer Patients

Study ID: NCT04537702

Conditions

Ovarian Cancer, Epithelial

Peritoneal Cancer

Fallopian Tube Cancer

Interventions

Streamlined Education

Traditional Education

Study Description

Brief Summary: Current guidelines recommend universal genetic testing for all patients with ovarian, fallopian and peritoneal cancer. The purpose of this trial is to investigate the non-inferiority of streamlined genetics education and testing for this patient population when compared to the traditional model of referral to genetic counseling. Patients will be randomized to either the streamlined or the traditional counseling arm. Those in the streamlined group will watch a brief educational video and have the option of immediate testing; The traditional counseling arm will instead be referred for a formal genetics consultation, after which they can choose to be tested. The primary outcome will be a patient reported outcome scale that assesses patient satisfaction with genetic counseling; patient anxiety and distress and cost effectiveness when using both strategies will also be evaluated. The study poses minimal risk to the patients that would not be encountered during standard of care genetic counseling.

Detailed Description: